Dual-capture CTC chip efficiently captures breast cancer cells

Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterisation Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumour cells (CTCs) in breast cancer...

Read the whole article on

More from